Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Additionally, exendin-4-modified deferoxamine (DFO) NPs (Ex-4@DFO NPs) have been developed to address limitations of traditional iron chelators
That means it is sold legally for use in scientific research but is not approved by the FDA as a medicine or health product
125 This is exemplified by immune evasion via antigen loss variants under immunotherapy or secondary mutations in driver oncogenes (e.g., EGFR-T790M, ALK-L1196M, BCR-ABL-T315I) in the context of targeted therapies
Adverse effectsnausea, vomiting, constipation, abdominal pain, and rare but serious gastrointestinal issuesoccur in 2050% of users depending on titration speed and individual tolerance
US$ 23.76
US$ 24.93
US$ 27.91
US$ 24.68
